HUT69285A - Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds. - Google Patents

Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds.

Info

Publication number
HUT69285A
HUT69285A HU9402835A HU9402835A HUT69285A HU T69285 A HUT69285 A HU T69285A HU 9402835 A HU9402835 A HU 9402835A HU 9402835 A HU9402835 A HU 9402835A HU T69285 A HUT69285 A HU T69285A
Authority
HU
Hungary
Prior art keywords
compds
sald
contg
prepare
ethanolamine derivatives
Prior art date
Application number
HU9402835A
Other languages
Hungarian (hu)
Inventor
Youichi Shiokawa
Kiyoshi Taniguchi
Masanobu Nagano
Kazuhiko Take
Takeshi Kato
Kazunori Tsubaki
Seiichiro Tabuchi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939308618A external-priority patent/GB9308618D0/en
Priority claimed from GB939322238A external-priority patent/GB9322238D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of HUT69285A publication Critical patent/HUT69285A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9402835A 1993-04-26 1994-04-22 Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds. HUT69285A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939308618A GB9308618D0 (en) 1993-04-26 1993-04-26 Ethanolamine derivatives
GB939322238A GB9322238D0 (en) 1993-10-28 1993-10-28 Enthanolamine derivatives

Publications (1)

Publication Number Publication Date
HUT69285A true HUT69285A (en) 1995-09-28

Family

ID=26302812

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402835A HUT69285A (en) 1993-04-26 1994-04-22 Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds.

Country Status (4)

Country Link
JP (1) JPH08509491A (en)
AU (1) AU6581294A (en)
HU (1) HUT69285A (en)
WO (1) WO1994025427A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977124A (en) * 1995-05-10 1999-11-02 Pfizer Inc. β-adrenergic agonists
AUPQ407699A0 (en) * 1999-11-16 1999-12-09 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
WO2002024632A2 (en) * 2000-09-18 2002-03-28 Glaxo Group Limited Substituted aminopropoxyaryl derivatives useful as agonists for lxr
DK1559427T3 (en) 2002-11-07 2011-04-26 Astellas Pharma Inc Drug for overactive bladder comprising acetic anilide derivative as the active ingredient
EP1682494A4 (en) * 2003-10-30 2006-11-08 Merck & Co Inc ARALKYLAMINES AS MODULATORS OF CANNABINOID RECEPTORS
CA3030551C (en) * 2016-07-07 2025-05-06 Corteva Agriscience Llc Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
EP0099707B1 (en) * 1982-07-16 1986-12-10 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8620951D0 (en) * 1986-08-29 1986-10-08 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
WO1994025427A1 (en) 1994-11-10
JPH08509491A (en) 1996-10-08
AU6581294A (en) 1994-11-21

Similar Documents

Publication Publication Date Title
HUP9602745A2 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
HUT69175A (en) Novel imidate derivs, pharmaceutical compounds contg. them and process to prepare them
EP0586034A3 (en) High pullulan content product, and its preparation and uses.
EP0620188A3 (en) Alpha-alumina powder and process for its production.
HUP9900973A3 (en) Carbamoyloxy derivatives of mutiline with antibacterial activity, pharmaceutical compns. contg. them and process for preparing the said compds.
HUT76292A (en) Antifungal sordaridin derivatives, pharmaceutical compns. contg. them and preparation and use of the said compds.
HUP9601565A2 (en) N-acyl-(2-aryl-cyclopropyl-methyl)-amine derivatives, pharmaceutical compns. contg. them and the use of the said compds.
HUP9900621A3 (en) 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives, process to prepare them and pharmaceuticals contg. the said compds.
HUP9601305A3 (en) Fluorine-containing benzoyl-guanidine derivatives, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
AU8271191A (en) Indolonaphthyridines, their production and use
HUP9602262A2 (en) Prostaglandin derivatives, pharmaceutical compns. contg. them and process for preparing the said compds.
GR3024654T3 (en) Benzofuranone and benzodifurantrione derivatives and process for the preparation of benzodifuranones.
HUT71793A (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds.
HUT69285A (en) Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds.
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
HUP9600998A3 (en) Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds.
HUP9700747A1 (en) Novel retinoids, pharmaceutical compns. contg. them and process for preparing the said compds.
HUP9602331A2 (en) Alkenyl-benzoyl-guanidine derivatives, pharmaceutical compns. contg. the said compds., process for preparing them and the use of the compds.
HRP930131A2 (en) Amino-ascorbic acid derivatives, process for the preparation and use thereof
HUP9600847A3 (en) Nonstochiometric compds. of primycins with ciclodextrin derivatives, pharmaceutical compns. contg. the said compds. and process for preparing them
EP0624567A3 (en) Derivatives of 3-fluorophenol, process for their preparation and their use.
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
EP0641764A3 (en) Process for the preparation of hydroxyalkylaminonitrobenzene derivatives.
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.
AU646941B2 (en) Process for the preparation of 2-pyridylsulfonylureas, and thiadiazoloptridines as intermediates in this process

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee